Skip to main content

Table 3 Immunosuppressive and immunomodulatory treatments at the time of blood sampling (N = 37) in patients (N = 25) with Susac syndrome (SuS), stratified according to anti-endothelial cell antibodies (AECA) serostatus

From: Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study

 

SuS samples, total

SuS samples, AECA-positive

SuS samples, AECA-negative

Untreated

19

4

15

Treateda

16

6

10

  Steroids

11

3

8

  IVIG

6

3

4

  Azathioprine

2

0

2

  Cyclophosphamide

3

0

3

  Mycophenolate mofetil

3

2

1

  Methotrexate

1

1

0

  Unknown

2

1

1

  1. aNote that the values in rows 3 to 8 of each column do not sum up to the values given in row 2 of the same column, since some patients received more than immunosuppressive/immunomodulatory treatment at the time of blood sampling. AECA, anti-endothelial cell antibodies; IVIG, intravenous immunoglobulins; SuS, Susac syndrome.
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094